Images from European Biotech and Pharma Partnering Conference in Osaka, Japan 2016


Leave a comment

bioXclusters reinforces its pathways to the Japanese market

Japan is the second largest pharmaceutical market in the world and leader in imports of the sector. Japanese life sciences companies are in the process of globalization and need alliances with foreign companies and biotechnology institutions to develop new medicines and incorporate new technologies. To that end, Japan is a strategic market for bioXclusters metacluster alliance. In collaboration with its Japanese Gateway Osaka Bio Headquarters, and with support of the EU-Japan Centre for industrial collaboration, bioXclusters organizes a mission to Japan in October 2017, following the 2016 success.

The organized mission allows to attend the following events. 

  • BioJapan (11-13 October 2017): Asia-wide benchmark trade fair for the global biotechnology industry that will bring together key business development and licensing professionals, R&D professionals and executives from biotechnology companies. This year’s fair also includes a HealthCare management and digital health area.

Aforementioned European Biotech and Pharma Partnering Conference in Osaka offers business contacts to industry professionals who are looking for Continue reading

Advertisements


Leave a comment

Focusing on international expansion to Canada and America in healthcare at BIOEurope Spring

Canada is a country presenting interesting assets for European companies undergoing international expansion, as expressed by the SME members of the bioXclusters+ regions, Auvergne-Rhône-Alps (Lyonbiopole), Bavaria (BioM), Catalonia (Biocat) and  Piedmont (bioPmed).

In order to build up collaboration opportunities, the bioXclusters+ alliance, the European Strategic Cluster Partnership on Personalised Healthcare – co-funded by the COSME Programme of the European Union -, has started discussions with some cluster organisations during BIO Intl. Convention in San Francisco in June 2016. Among them, TOHealth!, an industry-led public private partnership, working as the Toronto Cluster organisation, shares our strong interest to foster external relations and our a strong focus in Personalized Healthcare. Apart from this, a mutual collaboration MoU has been signed between TOHealth! (link) and bioXclusters plus in December 2016 for building bioXclusters+ gateways in Canada.

To that end, bioXclusters+ is organizing a session within BIO-Europe Spring 2017 to compare business environments for the Continue reading